Evoke Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Evoke Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-455	Closed	-$36K	–	1157
2022 Q3	$36K	Hold	455	–	–	﹤0.01%	566
2022 Q2	$34K	Buy	455 +368	+423%	+$27.6K	﹤0.01%	575
2022 Q1	$8K	Hold	87	–	–	﹤0.01%	820
2021 Q4	$10K	Sell	87 -48	-36%	-$5.79K	﹤0.01%	798
2021 Q3	$16K	Buy	+135	New	+$17.4K	﹤0.01%	674
2019 Q4	–	Sell	-670	Closed	-$51.1K	–	1489
2019 Q3	$51.1K	Buy	+670	New	+$55.7K	0.01%	461

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Evoke Wealth's XBI Position: Q4 2022 in Review

Evoke Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2022, closing a stake of 455 shares — an estimated $36K sold.

Evoke Wealth first reported a position in XBI in Q3 2019 and held it in 6 quarters. The position peaked at $51.1K in Q3 2019. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2022.

Evoke Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 455 State Street SPDR S&P Biotech ETF shares in Q4 2022, an estimated $36K.
Evoke Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 6 quarters.
Evoke Wealth's State Street SPDR S&P Biotech ETF position peaked at $51.1K in Q3 2019.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.